 | • レポートコード：MRC2Q12-17627 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、免疫剤のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 免疫剤のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 免疫剤の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 免疫剤のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの免疫剤の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の免疫剤の売上および2028年までの予測に焦点を当てています。 免疫剤のグローバル主要企業には、Abbott、Organon、Pfizer、Sandoz、Amneal Pharmaceuticals、Apotex、Teva Pharmaceuticals、Biocon、Bristol Myers Squibb、Merck、CSL Behring、Sanofi、Leading Pharma、Accord Healthcare Inc、Amgen、Nabi Biopharmaceuticals、Ascend Laboratories、Camber Pharmaceuticals Inc、Grifols USA、JOM Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 免疫剤市場は、タイプとアプリケーションによって区分されます。世界の免疫剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 抗リウマチ薬（DMARD）、免疫グロブリン、免疫調節剤、免疫抑制剤、モノクローナル抗体、その他 【アプリケーション別セグメント】 病院、診療所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 免疫剤製品概要 - タイプ別市場（抗リウマチ薬（DMARD）、免疫グロブリン、免疫調節剤、免疫抑制剤、モノクローナル抗体、その他） - アプリケーション別市場（病院、診療所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の免疫剤販売量予測2017-2028 - 世界の免疫剤売上予測2017-2028 - 免疫剤の地域別販売量 - 免疫剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別免疫剤販売量 - 主要メーカー別免疫剤売上 - 主要メーカー別免疫剤価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（抗リウマチ薬（DMARD）、免疫グロブリン、免疫調節剤、免疫抑制剤、モノクローナル抗体、その他） - 免疫剤のタイプ別販売量 - 免疫剤のタイプ別売上 - 免疫剤のタイプ別価格 ・アプリケーション別市場規模（病院、診療所、その他） - 免疫剤のアプリケーション別販売量 - 免疫剤のアプリケーション別売上 - 免疫剤のアプリケーション別価格 ・北米市場 - 北米の免疫剤市場規模（タイプ別、アプリケーション別） - 主要国別の免疫剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの免疫剤市場規模（タイプ別、アプリケーション別） - 主要国別の免疫剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の免疫剤市場規模（タイプ別、アプリケーション別） - 主要国別の免疫剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の免疫剤市場規模（タイプ別、アプリケーション別） - 主要国別の免疫剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの免疫剤市場規模（タイプ別、アプリケーション別） - 主要国別の免疫剤市場規模（トルコ、サウジアラビア） ・企業情報 Abbott、Organon、Pfizer、Sandoz、Amneal Pharmaceuticals、Apotex、Teva Pharmaceuticals、Biocon、Bristol Myers Squibb、Merck、CSL Behring、Sanofi、Leading Pharma、Accord Healthcare Inc、Amgen、Nabi Biopharmaceuticals、Ascend Laboratories、Camber Pharmaceuticals Inc、Grifols USA、JOM Pharmaceuticals ・産業チェーン及び販売チャネル分析 - 免疫剤の産業チェーン分析 - 免疫剤の原材料 - 免疫剤の生産プロセス - 免疫剤の販売及びマーケティング - 免疫剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 免疫剤の産業動向 - 免疫剤のマーケットドライバー - 免疫剤の課題 - 免疫剤の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Immunological Agents estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Immunological Agents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Immunological Agents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Immunological Agents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Immunological Agents include Abbott, Organon, Pfizer, Sandoz, Amneal Pharmaceuticals, Apotex, Teva Pharmaceuticals, Biocon and Bristol Myers Squibb, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Immunological Agents companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Immunological Agents market. Further, it explains the major drivers and regional dynamics of the global Immunological Agents market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Abbott
Organon
Pfizer
Sandoz
Amneal Pharmaceuticals
Apotex
Teva Pharmaceuticals
Biocon
Bristol Myers Squibb
Merck
CSL Behring
Sanofi
Leading Pharma
Accord Healthcare Inc
Amgen
Nabi Biopharmaceuticals
Ascend Laboratories
Camber Pharmaceuticals Inc
Grifols USA
JOM Pharmaceuticals
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Immunological Agents Segment by Type
Antirheumatic Drugs (DMARDs)
Immune Globulins
Immunomodulatory Agents
Immunosuppressive Agents
Monoclonal Antibodies
Other
Immunological Agents Segment by Application
Hospital
Clinics
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Immunological Agents market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Immunological Agents market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Immunological Agents, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Immunological Agents, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Immunological Agents revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Immunological Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Immunological Agents revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, Organon, Pfizer, Sandoz, Amneal Pharmaceuticals, Apotex, Teva Pharmaceuticals, Biocon and Bristol Myers Squibb, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Immunological Agents in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunological Agents companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunological Agents revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunological Agents Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Antirheumatic Drugs (DMARDs)
1.2.3 Immune Globulins
1.2.4 Immunomodulatory Agents
1.2.5 Immunosuppressive Agents
1.2.6 Monoclonal Antibodies
1.2.7 Other
1.3 Market by Application
1.3.1 Global Immunological Agents Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immunological Agents Market Perspective (2017-2028)
2.2 Immunological Agents Growth Trends by Region
2.2.1 Immunological Agents Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Immunological Agents Historic Market Size by Region (2017-2022)
2.2.3 Immunological Agents Forecasted Market Size by Region (2023-2028)
2.3 Immunological Agents Market Dynamics
2.3.1 Immunological Agents Industry Trends
2.3.2 Immunological Agents Market Drivers
2.3.3 Immunological Agents Market Challenges
2.3.4 Immunological Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunological Agents Players by Revenue
3.1.1 Global Top Immunological Agents Players by Revenue (2017-2022)
3.1.2 Global Immunological Agents Revenue Market Share by Players (2017-2022)
3.2 Global Immunological Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunological Agents Revenue
3.4 Global Immunological Agents Market Concentration Ratio
3.4.1 Global Immunological Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunological Agents Revenue in 2021
3.5 Immunological Agents Key Players Head office and Area Served
3.6 Key Players Immunological Agents Product Solution and Service
3.7 Date of Enter into Immunological Agents Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunological Agents Breakdown Data by Type
4.1 Global Immunological Agents Historic Market Size by Type (2017-2022)
4.2 Global Immunological Agents Forecasted Market Size by Type (2023-2028)
5 Immunological Agents Breakdown Data by Application
5.1 Global Immunological Agents Historic Market Size by Application (2017-2022)
5.2 Global Immunological Agents Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Immunological Agents Market Size (2017-2028)
6.2 North America Immunological Agents Market Size by Type
6.2.1 North America Immunological Agents Market Size by Type (2017-2022)
6.2.2 North America Immunological Agents Market Size by Type (2023-2028)
6.2.3 North America Immunological Agents Market Share by Type (2017-2028)
6.3 North America Immunological Agents Market Size by Application
6.3.1 North America Immunological Agents Market Size by Application (2017-2022)
6.3.2 North America Immunological Agents Market Size by Application (2023-2028)
6.3.3 North America Immunological Agents Market Share by Application (2017-2028)
6.4 North America Immunological Agents Market Size by Country
6.4.1 North America Immunological Agents Market Size by Country (2017-2022)
6.4.2 North America Immunological Agents Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Immunological Agents Market Size (2017-2028)
7.2 Europe Immunological Agents Market Size by Type
7.2.1 Europe Immunological Agents Market Size by Type (2017-2022)
7.2.2 Europe Immunological Agents Market Size by Type (2023-2028)
7.2.3 Europe Immunological Agents Market Share by Type (2017-2028)
7.3 Europe Immunological Agents Market Size by Application
7.3.1 Europe Immunological Agents Market Size by Application (2017-2022)
7.3.2 Europe Immunological Agents Market Size by Application (2023-2028)
7.3.3 Europe Immunological Agents Market Share by Application (2017-2028)
7.4 Europe Immunological Agents Market Size by Country
7.4.1 Europe Immunological Agents Market Size by Country (2017-2022)
7.4.2 Europe Immunological Agents Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunological Agents Market Size (2017-2028)
8.2 Asia-Pacific Immunological Agents Market Size by Type
8.2.1 Asia-Pacific Immunological Agents Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Immunological Agents Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Immunological Agents Market Share by Type (2017-2028)
8.3 Asia-Pacific Immunological Agents Market Size by Application
8.3.1 Asia-Pacific Immunological Agents Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Immunological Agents Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Immunological Agents Market Share by Application (2017-2028)
8.4 Asia-Pacific Immunological Agents Market Size by Region
8.4.1 Asia-Pacific Immunological Agents Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Immunological Agents Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Immunological Agents Market Size (2017-2028)
9.2 Latin America Immunological Agents Market Size by Type
9.2.1 Latin America Immunological Agents Market Size by Type (2017-2022)
9.2.2 Latin America Immunological Agents Market Size by Type (2023-2028)
9.2.3 Latin America Immunological Agents Market Share by Type (2017-2028)
9.3 Latin America Immunological Agents Market Size by Application
9.3.1 Latin America Immunological Agents Market Size by Application (2017-2022)
9.3.2 Latin America Immunological Agents Market Size by Application (2023-2028)
9.3.3 Latin America Immunological Agents Market Share by Application (2017-2028)
9.4 Latin America Immunological Agents Market Size by Country
9.4.1 Latin America Immunological Agents Market Size by Country (2017-2022)
9.4.2 Latin America Immunological Agents Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunological Agents Market Size (2017-2028)
10.2 Middle East & Africa Immunological Agents Market Size by Type
10.2.1 Middle East & Africa Immunological Agents Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Immunological Agents Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Immunological Agents Market Share by Type (2017-2028)
10.3 Middle East & Africa Immunological Agents Market Size by Application
10.3.1 Middle East & Africa Immunological Agents Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Immunological Agents Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Immunological Agents Market Share by Application (2017-2028)
10.4 Middle East & Africa Immunological Agents Market Size by Country
10.4.1 Middle East & Africa Immunological Agents Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Immunological Agents Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Immunological Agents Introduction
11.1.4 Abbott Revenue in Immunological Agents Business (2017-2022)
11.1.5 Abbott Recent Developments
11.2 Organon
11.2.1 Organon Company Details
11.2.2 Organon Business Overview
11.2.3 Organon Immunological Agents Introduction
11.2.4 Organon Revenue in Immunological Agents Business (2017-2022)
11.2.5 Organon Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Immunological Agents Introduction
11.3.4 Pfizer Revenue in Immunological Agents Business (2017-2022)
11.3.5 Pfizer Recent Developments
11.4 Sandoz
11.4.1 Sandoz Company Details
11.4.2 Sandoz Business Overview
11.4.3 Sandoz Immunological Agents Introduction
11.4.4 Sandoz Revenue in Immunological Agents Business (2017-2022)
11.4.5 Sandoz Recent Developments
11.5 Amneal Pharmaceuticals
11.5.1 Amneal Pharmaceuticals Company Details
11.5.2 Amneal Pharmaceuticals Business Overview
11.5.3 Amneal Pharmaceuticals Immunological Agents Introduction
11.5.4 Amneal Pharmaceuticals Revenue in Immunological Agents Business (2017-2022)
11.5.5 Amneal Pharmaceuticals Recent Developments
11.6 Apotex
11.6.1 Apotex Company Details
11.6.2 Apotex Business Overview
11.6.3 Apotex Immunological Agents Introduction
11.6.4 Apotex Revenue in Immunological Agents Business (2017-2022)
11.6.5 Apotex Recent Developments
11.7 Teva Pharmaceuticals
11.7.1 Teva Pharmaceuticals Company Details
11.7.2 Teva Pharmaceuticals Business Overview
11.7.3 Teva Pharmaceuticals Immunological Agents Introduction
11.7.4 Teva Pharmaceuticals Revenue in Immunological Agents Business (2017-2022)
11.7.5 Teva Pharmaceuticals Recent Developments
11.8 Biocon
11.8.1 Biocon Company Details
11.8.2 Biocon Business Overview
11.8.3 Biocon Immunological Agents Introduction
11.8.4 Biocon Revenue in Immunological Agents Business (2017-2022)
11.8.5 Biocon Recent Developments
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Company Details
11.9.2 Bristol Myers Squibb Business Overview
11.9.3 Bristol Myers Squibb Immunological Agents Introduction
11.9.4 Bristol Myers Squibb Revenue in Immunological Agents Business (2017-2022)
11.9.5 Bristol Myers Squibb Recent Developments
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Immunological Agents Introduction
11.10.4 Merck Revenue in Immunological Agents Business (2017-2022)
11.10.5 Merck Recent Developments
11.11 CSL Behring
11.11.1 CSL Behring Company Details
11.11.2 CSL Behring Business Overview
11.11.3 CSL Behring Immunological Agents Introduction
11.11.4 CSL Behring Revenue in Immunological Agents Business (2017-2022)
11.11.5 CSL Behring Recent Developments
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Immunological Agents Introduction
11.12.4 Sanofi Revenue in Immunological Agents Business (2017-2022)
11.12.5 Sanofi Recent Developments
11.13 Leading Pharma
11.13.1 Leading Pharma Company Details
11.13.2 Leading Pharma Business Overview
11.13.3 Leading Pharma Immunological Agents Introduction
11.13.4 Leading Pharma Revenue in Immunological Agents Business (2017-2022)
11.13.5 Leading Pharma Recent Developments
11.14 Accord Healthcare Inc
11.14.1 Accord Healthcare Inc Company Details
11.14.2 Accord Healthcare Inc Business Overview
11.14.3 Accord Healthcare Inc Immunological Agents Introduction
11.14.4 Accord Healthcare Inc Revenue in Immunological Agents Business (2017-2022)
11.14.5 Accord Healthcare Inc Recent Developments
11.15 Amgen
11.15.1 Amgen Company Details
11.15.2 Amgen Business Overview
11.15.3 Amgen Immunological Agents Introduction
11.15.4 Amgen Revenue in Immunological Agents Business (2017-2022)
11.15.5 Amgen Recent Developments
11.16 Nabi Biopharmaceuticals
11.16.1 Nabi Biopharmaceuticals Company Details
11.16.2 Nabi Biopharmaceuticals Business Overview
11.16.3 Nabi Biopharmaceuticals Immunological Agents Introduction
11.16.4 Nabi Biopharmaceuticals Revenue in Immunological Agents Business (2017-2022)
11.16.5 Nabi Biopharmaceuticals Recent Developments
11.17 Ascend Laboratories
11.17.1 Ascend Laboratories Company Details
11.17.2 Ascend Laboratories Business Overview
11.17.3 Ascend Laboratories Immunological Agents Introduction
11.17.4 Ascend Laboratories Revenue in Immunological Agents Business (2017-2022)
11.17.5 Ascend Laboratories Recent Developments
11.18 Camber Pharmaceuticals Inc
11.18.1 Camber Pharmaceuticals Inc Company Details
11.18.2 Camber Pharmaceuticals Inc Business Overview
11.18.3 Camber Pharmaceuticals Inc Immunological Agents Introduction
11.18.4 Camber Pharmaceuticals Inc Revenue in Immunological Agents Business (2017-2022)
11.18.5 Camber Pharmaceuticals Inc Recent Developments
11.19 Grifols USA
11.19.1 Grifols USA Company Details
11.19.2 Grifols USA Business Overview
11.19.3 Grifols USA Immunological Agents Introduction
11.19.4 Grifols USA Revenue in Immunological Agents Business (2017-2022)
11.19.5 Grifols USA Recent Developments
11.20 JOM Pharmaceuticals
11.20.1 JOM Pharmaceuticals Company Details
11.20.2 JOM Pharmaceuticals Business Overview
11.20.3 JOM Pharmaceuticals Immunological Agents Introduction
11.20.4 JOM Pharmaceuticals Revenue in Immunological Agents Business (2017-2022)
11.20.5 JOM Pharmaceuticals Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer